EP3110438
UspA2 prótínbyggingar og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.2.2015EP published:
2.1.2019EP application number:
15708341.1
EP translation filed:
20.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
19.2.2035Expiry date:
19.2.2025
Title:
USPA2 PROTEIN CONSTRUCTS AND USES THEREOF
Timeline
Today
20.2.2015EP application
2.1.2019EP Publication
20.2.2019Translation submitted
15.3.2019Registration published
19.2.2025Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut 89, 1330, Rixensart, BE
Inventor
Name:
BLAIS, NormandAddress:
Rixensart, BE
Name:
CASTADO, CindyAddress:
Rixensart, BE
Name:
CHOMEZ, PatrickAddress:
Rixensart, BE
Name:
DEWERCHIN, MarianneAddress:
Rixensart, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461943909 PDate:
24.2.2014Country:
US
Number:
201461946932 PDate:
3.3.2014Country:
US
Number:
201461946937 PDate:
3.3.2014Country:
US
Classification
Categories:
A61K 39/00, C07K 16/12, C07K 14/21
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 4.2.2019
Expires: 19.2.2020
Payer: Örn Þór, slf.
Number: 6
Paid: 16.1.2020
Expires: 19.2.2021
Payer: Örn Þór
Number: 7
Paid: 13.1.2021
Expires: 19.2.2022
Payer: Örn Þór slf.
Number: 8
Paid: 19.1.2022
Expires: 19.2.2023
Payer: Patice ehf.
Number: 9
Paid: 19.1.2023
Expires: 19.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.1.2024
Expires: 19.2.2025
Payer: Árnason Faktor ehf.